Director, New Products & Business Development, Solid Tumors

Johnson & Johnson•Horsham, PA

14h•Onsite

About The Position

Johnson & Johnson is recruiting a Director, New Products & Business Development, Solid Tumors, for a highly visible, US-based cross-functional leadership role. The Director will define and execute US pre-launch strategy while shaping key global decisions, translating market, clinical, and commercial insights into strategic priorities. The role influences global portfolio investment, development, launch plans, and execution through a US perspective, aligning stakeholders and making trade-offs across competing opportunities. It offers enterprise-wide experience in preparation for future senior leadership opportunities. The Director leads US launch readiness and marketing excellence, develops asset and indication strategies, and represents US customer, marketplace, and competitive considerations in global strategy. The role also provides US commercial input on selected business development opportunities, including opportunity assessment, product attributes, forecasts, and investment decisions.

Requirements

Bachelor’s degree required.
At least 8 years of business experience, with significant pharmaceutical, biotechnology, or healthcare industry focus.
Experience with in-line launches required.
Strong understanding of US market dynamics, customer insights, competitive strategy, evidence generation, and launch readiness planning.
Experience integrating analytics, forecasting, valuation, and market research into strategic recommendations.
Demonstrated ability to lead cross-functional strategy in a matrixed environment and influence senior stakeholders without direct authority.
Ability to operate in ambiguity, shape strategy early, and move work from insight to decision.
Strong communication skills, including the ability to translate complex asset strategy into clear decisions, trade-offs, and action plans.
Ability to balance enterprise and global inputs with a clear perspective on requirements for US launch success.

Nice To Haves

MBA or advanced degree.
Experience in oncology.
Commitment to learning emerging technologies, such as AI, through exploration, iteration, and applying new tools over time.
Skills listed as preferred: Alliance Formation, Business Development, Business Valuations, Collaboration, Competitive Landscape Analysis, Customer Intelligence, Due Diligence, Lateral Leadership, Market Research, Negotiation, Process Improvements, Product Marketing Sales, Product Strategies, Relationship Building, Strategic Change, Strategic Thinking, Tactical Planning, and Technical Credibility.

Responsibilities

Lead cross-functional integrated strategy teams to develop and execute asset and indication strategies and plans for US launch readiness.
Connect strategy, plans, decisions, and execution into a cohesive launch narrative with shared objectives and outcomes.
Translate complexity into clear priorities and actions; anticipate risks, opportunities, dependencies, and strategic implications; shape solutions and drive informed decisions.
Influence and align cross-functional stakeholders, maintain accountability for launch readiness outcomes, address barriers, and ensure critical decisions are made.
Mobilize launch readiness teams around priorities and support organizational readiness and transition to in-line ownership.
Lead US marketing excellence, including positioning, value proposition development, and input into US label planning.
Develop and implement early market-shaping strategies, including unbranded market development, evidence generation, and Key Opinion Leader engagement.
Represent the US point of view in global strategy, plans, and execution, ensuring US customer, marketplace, and competitive considerations inform global decisions.
For products progressing through investment governance, ensure US commercial insights inform clinical development plans, competitive vision, Target Product Profile, and value proposition.
For launch preparation, represent the US market in global forums and provide strategic input on global strategy, positioning, trademark and branding, and pre-launch initiatives.
Partner with Analytics to develop customer-insight-based forecasts and valuations that guide stage-gate decisions.
Lead US input on selected business development opportunities, including competitive landscape assessment, opportunity identification, and prioritization of required product attributes.
Provide a US commercial perspective, including sales and OPEX forecasts, to inform opportunity evaluation and investment decisions.